A handful of specialties are calling for targeted relief payments from the federal government, saying that they have been left out of...
“The study is innovative and important in being the first prospective study to evaluate the association between menstrual cup use and IUD...
Learning to live with COVID-19: Postpandemic life will be reflected in how effectively we leverage this crisis
Four strategies can help us navigate through the COVID-19 health emergency, and lessons learned can guide thinking on future...
News for Your Practice
STOWE, VT. – The disorder is associated with greater disability than nonmenstrual migraine and may be harder to...
Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...
Sexually transmitted diseases have broad-reaching impact on women’s health and maternal-child health. ObGyn engagement in evidence-based...
Labeling updates include more information on using certain MS drugs during pregnancy and breastfeeding.
A survey suggests a lack of discussion about clinical trials between doctors and patients with gynecologic cancers.